Canopy Growth Enters Agreement with Australian Victoria State Government

Ontario-based cannabis producer Canopy Growth Corporation (TSX: WEED) has signed a Memorandum of Understanding (MOU) with the Victorian State Government to develop research capabilities to produce medical cannabis in Australia. Victoria was the first state in Australia to legalize medical cannabis.

The work will focus on medical applications for cannabis genetics, strain development, cultivation, and processing. According to the parties, the partnership will create “a leadership position for Australia and Canopy Growth in the Asia Pacific geography.”

The stock was up 3% midday at CAD $30.11. The company is now trading at 121 times sales and 9 times book value.

Mark Zekulin, President of Canopy Growth, said, “… we hope to increase innovation and institutional understanding in the Australian medical cannabis market to ensure that our globally recognized genetics are available in Australia …” Cannabis genetics from Canopy Growth’s Canadian operations have already been successfully imported into the country and are growing healthily in the state of Victoria.

Specific capabilities include genome sequencing, comprehensive metabolome analysis and chemo-typing, and technologies for accelerated precision breeding.

Canopy Growth, which operates in seven countries, is one of the world’s largest cannabis and hemp companies, offering brands in dried, oil and Softgel capsule forms. It serves over a third of the medical cannabis patients in the Canada, exceeding 69,000 people.

Its network includes a partnership with partly-owned Australian cannabis company, AusCann, based in Western Australia. AusCann will directly benefit by being able to readily access Canopy’s base of genetics to advance its medical research initiatives and development.

Canopy Growth Enters Agreement with Australian Victoria State Government

About Cannin: Your Cannabis Stocks Resource

Cannin is your #1 trusted resource for cannabis stocks. Our global team of experts evaluates all emerging cannabis stock investing opportunities. We aggregate hundreds of hours of financial research and provide tips on the best cannabis stocks for 2020.

Use Cannin as your resource for:

Market analysts expect the marijuana and hemp industry will have an annual value exceeding $75 Billion in the next decade. Is it too late to invest in marijuana stocks? No! This is the perfect time to invest.

Are you looking to buy stock in hemp companies or marijuana companies for 2020? Interested in new penny hemp stock companies? Looking for the best Canadian cannabis stocks to invest in? Looking to leverage the power of algorithmic stock trading to beat the cannabis market? We can help.

Are you interested in cannabis stocks like Curaleaf, Trulieve, Aurora Cannabis, Charlotte’s Web, Canopy Growth, or Hemp Inc.?

Predict price movements of cannabis stocks several hours in advance with our proprietary algorithmic stock trading software.

+25% Gains in 2020
+49.8% Gains in 2019
Backtested since 2012

We’re so confident you’ll love our algotrading cannabis stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.

Profit from the best cannabis stocks – we’ll show you how at cannin.com.

Marijuana Stocks, Pot Stocks, Algorithmic Stock Trading, Best Hemp Stocks to Invest In

Canopy Growth Enters Agreement with Australian Victoria State Government